Catherine P. Leith

3.3k total citations · 1 hit paper
38 papers, 2.3k citations indexed

About

Catherine P. Leith is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Catherine P. Leith has authored 38 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 14 papers in Hematology. Recurrent topics in Catherine P. Leith's work include Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Catherine P. Leith is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Catherine P. Leith collaborates with scholars based in United States, Greece and Canada. Catherine P. Leith's co-authors include Cheryl L. Willman, David R. Head, Kenneth J. Kopecky, Frederick R. Appelbaum, Thomas S. McConnell, Marilyn L. Slovak, I‐Ming Chen, John E. Godwin, Michael R. Grever and James K. Weick and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Catherine P. Leith

38 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

1997 696 citations Catherine P. Leith, Kenneth J. Kopecky et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine P. Leith United States	17	1.4k	1.0k	921	500	358	38	2.3k
John A. Liu Yin United Kingdom	20	2.1k 1.5×	650 0.6×	833 0.9×	574 1.1×	523 1.5×	43	2.7k
Stefan Früehauf Germany	31	1.6k 1.2×	1.0k 1.0×	1.1k 1.2×	167 0.3×	584 1.6×	119	3.1k
Marie‐Thérèse Daniel France	30	1.4k 1.0×	818 0.8×	1.2k 1.3×	663 1.3×	499 1.4×	58	2.8k
Seisho Takeuchi Japan	31	965 0.7×	1.4k 1.4×	1.9k 2.1×	722 1.4×	285 0.8×	90	3.6k
DC Arthur United States	25	1.6k 1.2×	953 0.9×	754 0.8×	793 1.6×	516 1.4×	47	3.0k
Cristina Papayannidis Italy	26	1.4k 1.0×	882 0.9×	1.0k 1.1×	951 1.9×	508 1.4×	160	2.7k
Masayuki Towatari Japan	27	1.6k 1.1×	570 0.6×	1.7k 1.8×	320 0.6×	595 1.7×	40	2.9k
W. D. Ludwig Germany	21	1.2k 0.8×	541 0.5×	691 0.8×	679 1.4×	291 0.8×	48	2.0k
Tanya Trippett United States	24	380 0.3×	655 0.6×	580 0.6×	525 1.1×	235 0.7×	79	1.9k
Stefania Paolini Italy	20	1.3k 0.9×	430 0.4×	376 0.4×	644 1.3×	574 1.6×	88	1.9k

Countries citing papers authored by Catherine P. Leith

Since Specialization

Citations

This map shows the geographic impact of Catherine P. Leith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine P. Leith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine P. Leith more than expected).

Fields of papers citing papers by Catherine P. Leith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine P. Leith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine P. Leith. The network helps show where Catherine P. Leith may publish in the future.

Co-authorship network of co-authors of Catherine P. Leith

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine P. Leith. A scholar is included among the top collaborators of Catherine P. Leith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine P. Leith. Catherine P. Leith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dorfman, David M., William Karlon, Michael Keeney, et al.. (2020). Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey. Archives of Pathology & Laboratory Medicine. 145(3). 336–342. 2 indexed citations

Pagenkopf, Adam, Binod Dhakal, Chelsea Hope, et al.. (2017). Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT). Blood. 130. 1756–1756. 1 indexed citations

Leith, Catherine P.. (2017). Cost-Effective Flow Cytometry Testing Strategies. Clinics in Laboratory Medicine. 37(4). 915–929. 5 indexed citations

Hope, Chelsea, Simon J. Foulcer, Justin C. Jagodinsky, et al.. (2016). Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Blood. 128(5). 680–685. 115 indexed citations

Tseng, Victor, et al.. (2014). Efficient assessment of peripheral blood lymphocytosis in adults: developing new thresholds for blood smear review by pathologists. Clinical Chemistry and Laboratory Medicine (CCLM). 52(12). 1763–70. 11 indexed citations

Hope, Chelsea, Erika Héninger, Jeffrey L. Jensen, et al.. (2014). TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood. 123(21). 3305–3315. 75 indexed citations

Yang, David T., et al.. (2010). Use of Tissue Microarray and Automated Quantitative Analysis for Screening and Validation of Potential Biomarkers in Mantle Cell Lymphoma. Applied immunohistochemistry & molecular morphology. 19(1). 62–69. 6 indexed citations

Taylor, Martin I., Gwen S. Rees, Anthony Oojageer, et al.. (2010). Comparison of germ line minisatellite mutation detection at the CEB1 locus by Southern blotting and PCR amplification. Mutagenesis. 25(4). 343–349. 1 indexed citations

Markovina, Stephanie, Natalie S. Callander, Shelby L. O’Connor, et al.. (2010). Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells. Molecular Cancer. 9(1). 176–176. 97 indexed citations

10.

Markovina, Stephanie, Natalie S. Callander, Shelby L. O’Connor, et al.. (2008). Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells. Molecular Cancer Research. 6(8). 1356–1364. 118 indexed citations

11.

Wheeler, Deric L., et al.. (2005). Overexpression of Protein Kinase C-ε in the Mouse Epidermis Leads to a Spontaneous Myeloproliferative-Like Disease. American Journal Of Pathology. 166(1). 117–126. 19 indexed citations

12.

Viswanatha, David S., et al.. (2000). Blastic Mantle Cell Leukemia: An Unusual Presentation of Blastic Mantle Cell Lymphoma. Modern Pathology. 13(7). 825–833. 43 indexed citations

13.

Leith, Catherine P., Kenneth J. Kopecky, I‐Ming Chen, et al.. (1999). Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.. Blood. 94(3). 1086–99. 479 indexed citations

14.

Leith, Catherine P.. (1998). Multidrug resistance in leukemia. Current Opinion in Hematology. 5(4). 287–291. 39 indexed citations

15.

Leith, Catherine P., Aroop Mangalik, & Kathy Foucar. (1997). A B-cell “Chameleon”: Striking clinical, morphological, and immunophenotypic diversity of a single low-grade B cell clone. Human Pathology. 28(1). 104–108. 2 indexed citations

16.

Leith, Catherine P., Kenneth J. Kopecky, John E. Godwin, et al.. (1997). Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study. Blood. 89(9). 3323–3329. 696 indexed citations breakdown →

17.

Leith, Catherine P., et al.. (1996). Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.. PubMed. 10(8). 1274–82. 22 indexed citations

18.

Leith, Catherine P. & Cheryl L. Willman. (1996). Prognostic markers in acute leukemia. Current Opinion in Hematology. 3(4). 329–334. 6 indexed citations

19.

Leith, Catherine P., et al.. (1994). The Presence of bcl-1 and bcl-2 Gene Rearrangements in Diffuse Small Cleaved-Cell Lymphoma. Diagnostic Molecular Pathology. 3(3). 178–183. 2 indexed citations

20.

Leith, Catherine P., Catherine Spier, TM Grogan, et al.. (1992). Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsets.. Journal of Clinical Oncology. 10(8). 1259–1265. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact